Biodexa Pharmaceuticals Plc (BDRX) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2025)

-£6.4M

Total Assets (FY2025)

£18.2M

Total Equity (FY2025)

£11.4M

Cash Flows from Operating Activities (FY2025)

-£5.6M

Source: Biodexa Pharmaceuticals Plc 20-F filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.